Baudax Bio Reports Third Quarter 2021 Financial Results and Business Highlights
November 04, 2021 07:00 ET
|
Baudax Bio, Inc.
ANJESO® Revenue Up 40% in Q3 2021 over Q2 2021 and Up Over 300% in Q3 2021 over Q3 2020 Solid Growth in End User Demand Units, September 2021 Strongest Month Launch-to-Date, Indicating Growing...
Baudax Bio to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 4, 2021
October 28, 2021 07:00 ET
|
Baudax Bio, Inc.
MALVERN, Pa., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today...
Baudax Bio to Present at the NobleCon Pain Management Investor Forum
October 05, 2021 07:00 ET
|
Baudax Bio, Inc.
MALVERN, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today...
Baudax Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 01, 2021 16:17 ET
|
Baudax Bio, Inc.
MALVERN, Pa., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today...
Baudax Bio to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 16, 2021 07:00 ET
|
Baudax Bio, Inc.
MALVERN, Pa., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today...
Baudax Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
September 07, 2021 07:00 ET
|
Baudax Bio, Inc.
MALVERN, Pa., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today...
Baudax Bio Reports Second Quarter 2021 Financial Results and Highlights
August 05, 2021 07:00 ET
|
Baudax Bio, Inc.
Total Number of ANJESO® Vials Sold to End-Users in the Second Quarter 2021 Match Total Vials Sold for the Full Year 2020 ANJESO® Demand Showing Strong Growth Based on Several Key...
Baudax Bio Announces Date of Reconvened Special Meeting
July 30, 2021 16:05 ET
|
Baudax Bio, Inc.
MALVERN, Pa., July 30, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) (the “Company”), a pharmaceutical company focused on commercializing and developing innovative products for acute care...
Baudax Bio to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021
July 29, 2021 07:00 ET
|
Baudax Bio, Inc.
MALVERN, Pa., July 29, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on developing and commercializing innovative products for acute care settings, today...
Leading Independent Proxy Advisory Firm Glass Lewis & Co. Recommends Baudax Bio Shareholders Vote “For” the Proposed Additional Authorized Shares at Upcoming Special Meeting of Shareholders
July 01, 2021 07:00 ET
|
Baudax Bio, Inc.
MALVERN, Pa., July 01, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on developing and commercializing innovative products for acute care settings, today...